Evidence map›Paper›PMID 40236931›Full record

ArticleFuture healthcare journal2025

The future of nephrology in 2050.

Melanie My Chan, Omid Sadeghi-Alavijeh, Rhys Dr Evans, Andrew Davenport, Dorothea Nitsch

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Future healthcare journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Healthcare on a burning planet.Future healthcare journal · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Melanie My ChanMRC Laboratory of Medical Sciences, Imperial College London, London, UK.
Omid Sadeghi-AlavijehUCL Centre for Kidney and Bladder Health, University College London, London, UK.
Rhys Dr EvansUCL Centre for Kidney and Bladder Health, University College London, London, UK.
Andrew DavenportUCL Centre for Kidney and Bladder Health, University College London, London, UK.
Dorothea NitschDepartment of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As medicine advances at an unprecedented pace, the field of nephrology is poised for transformative change. By 2050, breakthroughs in kidney disease prevention, dialysis, transplantation, and omics-driven precision medicine could redefine patient care and outcomes. Here, we share our perspectives on the challenges faced and how changes in health policy, emerging technologies, novel therapies, and data-driven approaches might shape the future of nephrology. From innovative dialysis solutions to xenotransplantation and AI-powered diagnostics, we explore the possibilities that could revolutionise kidney health in the decades to come.

Indexed as

Chronic kidney diseaseDialysisGenomicsRenalTransplant

Identifiers

PMID40236931
PMCPMC11998293

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.